emerg
preemerg
coronavirus
cov
pose
global
threat
requir
immedi
intervent
rapid
intervent
necessit
capac
gener
grow
genet
manipul
infecti
cov
order
rapidli
evalu
pathogen
mechan
host
tissu
permiss
candid
antivir
therapeut
efficaci
cov
encod
largest
viral
rna
genom
nucleotid
length
therebi
complic
effici
engin
genom
deconstruct
genom
manag
fragment
afford
plastic
necessari
rapidli
introduc
target
genet
chang
parallel
assort
mutat
fragment
maxim
genom
stabil
time
protocol
describ
welldevelop
revers
genet
platform
strategi
cov
compris
partit
viral
genom
independ
dna
fragment
depend
cov
genom
subclon
plasmid
increas
stabil
eas
genet
manipul
amplif
coronaviru
genom
conveni
partit
introduc
type
ii
iig
restrict
enzym
recognit
site
confer
direct
clone
sinc
restrict
site
leav
uniqu
overhang
adjoin
fragment
reconstruct
fulllength
genom
achiev
standard
dna
ligat
compris
equal
molar
ratio
fragment
use
method
recombin
cov
rapidli
gener
use
investig
host
rang
gene
function
pathogenesi
candid
therapeut
emerg
preemerg
cov
vitro
vivo
human
coronavirus
hcov
first
identifi
primarili
associ
mild
upper
respiratori
tract
infect
potenti
progress
sever
respiratori
diseas
young
children
elderli
immunocompromis
individu
although
addit
hcov
known
circul
time
strain
cultur
therefor
infect
model
understand
cov
diseas
sever
southeast
asia
sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
late
caus
acut
respiratori
distress
syndrom
agedepend
mortal
rate
clearli
demonstr
hcov
emerg
pathogen
pandem
potenti
portent
worldwid
pandem
mobil
scientif
commun
lead
robust
public
health
intervent
strategi
control
epidem
moreov
outbreak
spur
academ
interest
cov
gene
function
pathogen
mechan
associ
sarscovinduc
diseas
lead
develop
therapeut
countermeasur
avail
revers
genet
robust
vitro
replic
vivo
anim
model
human
diseas
sarscov
becom
intens
studi
prototyp
hcov
research
sarscov
research
prompt
gener
novel
anim
model
provid
insight
genet
chang
sarscov
genom
modul
respiratori
pathogenesi
impact
sarscov
host
innat
adapt
immun
respons
role
host
gene
regul
sarscov
pathogenesi
mice
novel
strategi
develop
vaccin
therapeut
countermeasur
two
novel
hcov
identifi
shortli
emerg
sarscov
nearli
decad
later
world
saw
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
fig
merscov
caus
acut
respiratori
distress
syndrom
ard
sever
pneumonialik
symptom
multiorgan
failur
case
fatal
rate
human
case
merscov
predominantli
observ
saudi
arabia
middl
east
merscovinfect
individu
also
travel
intern
illustr
potenti
global
spread
exampl
south
korean
nativ
return
home
middl
east
may
initi
outbreak
infect
peopl
result
mortal
nationwid
econom
crisi
transmiss
merscov
mostli
observ
among
health
care
worker
hospit
set
accumul
evid
indic
middl
eastern
individu
work
close
contact
dromedari
camel
increas
risk
acquir
merscov
camel
suspect
intermedi
host
bat
human
repeatedli
allow
reemerg
merscov
human
popul
though
camel
show
mild
symptomolog
merscov
infect
zoonot
cov
infect
highli
pathogen
anim
demonstr
recent
emerg
porcin
cov
unit
state
porcin
epidem
diarrhea
viru
pedv
caus
sever
disrupt
pork
industri
death
ten
million
anim
first
year
mortal
rate
fig
pedv
merscov
sarscov
hcov
hcov
thought
emerg
bat
reservoir
thought
origin
among
bovin
coronavirus
preemerg
sarslik
cov
identifi
horsesho
bat
found
pois
entri
human
popul
fig
importantli
much
hcov
research
last
year
possibl
capac
gener
infecti
clone
use
highli
effici
revers
genet
platform
coupl
robust
small
anim
model
human
diseas
revers
genet
system
coronavirus
difficult
achiev
larg
size
viral
rna
genom
genom
stabil
bacteri
vector
difficulti
drive
fulllength
kb
rna
transcript
vitro
poor
transfect
effici
low
infect
viral
genom
first
molecular
clone
develop
transmiss
gastroenter
viru
tgev
use
target
splice
junction
increas
genom
stabil
lowcopi
baculoviru
vector
fig
month
later
group
publish
altern
tgev
revers
genet
strategi
appli
techniqu
group
murin
coronaviru
final
innov
cov
molecular
clone
design
insert
fulllength
hcov
molecular
clone
vaccinia
viru
approach
proven
potenti
power
system
probe
role
cov
gene
replic
pathogenesi
review
primarili
focus
revers
genet
strategi
develop
baric
laboratori
technolog
partit
cov
genom
discret
fragment
use
class
ii
iig
restrict
endonucleas
systemat
seamlessli
assembl
fulllength
cdna
genom
cov
vitro
transcript
transfect
fulllength
genom
permiss
cell
recombin
virus
recov
contain
genet
content
molecular
clone
although
revers
genet
system
rg
describ
achiev
promin
shortli
emerg
sarscov
platform
use
gener
cov
infecti
clone
span
nearli
entir
breadth
coronavirida
famili
includ
pathogen
virus
group
alphacoronavirus
group
betacoronavirus
fig
entir
cov
fragment
join
type
ii
iig
restrict
site
eg
bgli
sapi
bsai
support
direct
seamless
ligat
fulllength
genom
fig
type
ii
eg
sapi
restrict
enzym
recognit
sequenc
separ
cleavag
site
one
variabl
nucleotid
leav
three
four
nucleotid
uniqu
overhang
fig
thu
enzym
leav
uniqu
end
provid
direction
multiseg
assembl
moreov
recognit
site
palindrom
allow
seamless
assembl
compon
cdna
clone
fulllength
gene
genom
orient
recognit
sequenc
extern
cleavag
site
upon
digest
ligat
restrict
site
lost
seamlessli
join
cdna
preserv
orf
integr
sequenc
authent
second
approach
use
type
iig
eg
bgli
restrict
endonucleas
palindrom
restrict
site
bisect
variabl
domain
five
nucleotid
also
leav
differ
overhang
direct
assembl
larg
genom
molecul
fig
instanc
restrict
site
retain
assembl
product
coronaviru
genom
unstabl
bacteria
junction
orient
within
toxic
sequenc
domain
therebi
bisect
region
toxic
increas
compon
clone
stabil
plasmid
digest
type
ii
iig
restrict
enzym
isol
fragment
cov
genom
fig
fragment
resolv
agaros
gel
purifi
ligat
fig
follow
ligat
coronaviru
genomelength
mrna
vitro
transcrib
promot
ad
end
utr
instanc
strong
stop
site
mutat
promot
fulllength
transcript
synthesi
vitro
transcript
reaction
result
genomelength
mrna
electropor
permiss
mammalian
cell
line
fig
clone
success
viral
fit
measur
plaqu
assay
growth
curv
fig
viral
replic
cov
uniqu
capac
gener
nest
set
subgenom
viral
rna
sgrna
harbor
similar
untransl
region
utr
fig
northern
blot
analysi
cov
rna
andor
pcr
viral
cdna
afford
visual
sgrna
confirm
replicationcompet
viru
fig
effici
rg
exemplifi
fact
infecti
clone
sarscov
icsar
gener
publish
within
week
initi
public
sarscov
urbani
strain
sequenc
fig
use
dna
synthesi
compani
synthes
fulllength
coronaviru
genom
achiev
use
hcov
model
final
group
appli
approach
gener
stabl
molecular
clone
flavivirus
includ
dengu
newli
emerg
zika
viru
importantli
fragment
hcov
genom
confer
addit
biolog
safeti
benefit
revers
genet
system
would
otherwis
maintain
cov
genom
cdna
molecul
compris
greater
fulllength
genom
sanction
nih
guidelin
research
involv
recombin
synthet
nucleic
acid
molecul
nih
guidelin
april
section
indic
recombin
synthet
nucleic
acid
molecul
contain
twothird
genom
eukaryot
viru
may
propag
maintain
cell
tissu
cultur
use
contain
moreov
fulllength
cov
genom
encod
select
agent
sarscov
regul
feder
select
agent
program
wwwselectagentsgov
must
handl
accord
specif
guidelin
sgrna
gener
activ
coronaviru
replic
visual
northern
blot
left
pcr
right
use
biotinyl
radioact
probe
cov
ngene
sgrna
speci
visual
run
rna
isol
covinfect
cell
northern
gel
left
northern
blot
imag
reprint
altern
pcr
primer
contain
within
leader
sequenc
ngene
use
gener
pcr
product
viral
cdna
order
visual
sgrna
signifi
product
cov
replic
right
pcr
product
confirm
product
replic
merscov
lung
mous
permiss
merscov
infect
transgen
mous
lung
nonpermiss
wildtyp
mous
lung
method
use
confirm
product
cov
replic
follow
rg
clone
gener
partit
sarscov
genom
allow
effici
handl
genom
fragment
standard
contain
condit
fig
reconstruct
fulllength
genom
encod
cov
restrict
contain
sarscov
merscov
preemerg
bat
cov
fragment
ligat
subsequ
step
execut
condit
includ
recoveri
recombin
virus
fig
one
advantag
segment
molecular
clone
design
mutagenesi
occur
parallel
multipl
fragment
individu
fragment
reassort
make
larger
panel
deriv
mutant
encod
mutat
subset
fig
exampl
earli
applic
includ
introduct
mutat
sarscov
genom
differ
genom
transcript
regulatori
sequenc
therebi
demonstr
first
time
transcript
regulatori
circuit
viru
could
rewir
applic
rg
ratifi
ensu
report
describ
causeandeffect
relationship
sitedirect
mutat
introduc
viral
genom
alter
viral
fit
vivo
pathogenesi
phenotyp
semin
pathogenesi
studi
rg
use
valid
six
mutat
acquir
mous
adapt
sarscov
urbani
strain
inde
caus
lung
patholog
associ
sever
acut
respiratori
distress
syndrom
sinc
mutat
dispers
across
entir
genom
rg
prove
effici
method
introduc
six
mutat
simultan
order
gener
robust
mouseadapt
sarscov
strain
notabl
sarscov
novel
viru
strain
rg
effect
method
valid
koch
postul
demonstr
causeandeffect
relationship
nearli
decad
research
strain
continu
play
domin
role
sarscov
mous
pathogenesi
studi
includ
vaccin
therapeut
evalu
today
research
environ
studi
would
consid
gainoffunct
gof
studi
therebi
would
subject
increas
govern
oversight
would
inevit
stymi
progress
understand
molecular
mechan
govern
emerg
coronaviru
pathogenesi
host
rang
receptor
usag
viru
replic
vaccin
therapeut
efficaci
notabl
sarscov
gainoffunct
gof
studi
yield
invalu
inform
regard
role
viral
protein
pathogenesi
anim
model
tissu
cultur
studi
appli
combin
technolog
gof
studi
rg
essenti
futur
research
emerg
preemerg
coronavirus
recent
rg
applic
extend
merscov
wherein
replicationcompet
merscov
express
tomato
red
fluoresc
protein
trfp
rapidli
gener
reproduc
fig
infecti
clone
icmerscovtrfp
sinc
appli
understand
host
factor
restrict
merscov
infect
figur
demonstr
icmerscovtrfp
use
facilit
map
specif
amino
acid
host
dipeptidyl
peptidas
receptor
necessari
permit
merscov
infect
replic
human
mous
chang
minimum
two
amino
acid
mous
protein
confer
effici
infectionrepl
merscov
determin
express
trfp
icmerscovtrfp
viru
fig
follow
protocol
outlin
rg
use
gener
infecti
clone
merscov
provid
detail
method
build
recombin
coronavirus
use
techniqu
seven
plasmid
contain
mer
fragment
af
clone
pcrxltopo
invitrogen
carlsbad
ca
vector
appropri
restrict
enzym
buffer
screen
mer
fragment
see
tabl
lb
broth
supplement
carbenicillin
kanamycin
growth
bacteri
cell
follow
plasmid
transform
lb
plate
supplement
carbenicillin
kanamycin
growth
bacteri
cell
follow
plasmid
transform
qiaprep
spin
miniprep
kit
qiagen
mmessag
mmachin
transcript
kit
ambion
sequenc
verifi
coloni
correct
insert
prior
advanc
ligat
synthesi
genomelength
rna
sequenc
primer
space
approxim
nucleotid
apart
along
cov
fragment
interest
primer
also
design
sequenc
plasmid
backbon
insert
cov
fragment
select
replic
plasmid
librari
correct
insert
size
sequenc
merscov
fragment
fig
digest
plasmid
dna
appropri
restrict
enzym
see
tabl
mersa
mersf
first
digest
nrui
noti
h
respect
accord
manufactur
instruct
see
note
b
cip
treat
fragment
ad
unit
cip
per
digest
volum
incub
h
c
reaction
extract
dna
mix
volum
dna
digest
reaction
volum
sodium
acet
volum
chloroform
mix
invers
min
separ
aqueousorgan
phase
centrifug
max
speed
min
remov
aqueou
layer
clean
label
tube
add
six
volum
isopropyl
alcohol
mix
incub
room
temperatur
min
e
pellet
dna
centrifug
max
speed
min
f
remov
supernat
add
ml
icecold
ethanol
per
tube
repeat
centrifug
g
care
remov
supernat
add
ml
icecold
ethanol
per
tube
repeat
centrifug
k
digest
plasmid
contain
mer
fragment
b
e
bgli
h
accord
manufactur
instruct
isol
fragment
gel
electrophoresi
agaros
gel
ethidium
bromid
allow
gel
run
distinct
easili
isol
insert
interest
seen
see
note
remov
band
interest
fragment
see
tabl
purifi
fragment
gel
use
qiaquick
gel
extract
kit
accord
manufactur
instruct
band
fragment
may
pool
extract
togeth
chloroform
extract
gelpurifi
fragment
step
quantit
dna
fragment
use
dna
spectrophotomet
nanodrop
use
base
pair
length
fragment
determin
molecul
copi
number
number
copi
ng
insert
dna
moleculesmol
insert
length
base
pair
gmol
electropor
neg
control
use
remaind
ngene
transcript
subhead
step
add
icecold
cell
suspens
immedi
transfer
cuvett
biorad
gene
pulser
excel
electropor
similar
devic
set
v
puls
three
time
remov
cuvett
allow
sit
room
temperatur
without
agit
min
transfer
electropor
cell
prepar
flask
ml
harvest
medium
gentli
rock
cell
allow
even
distribut
check
cytopath
effect
electropor
control
next
h
wildtyp
merscov
produc
cytopath
effect
within
h
fig
syncytia
format
result
fusion
neighbor
cell
via
excess
spike
glycoprotein
seen
within
h
electropor
fig
see
note
e
plaqu
visibl
stain
pick
plaqu
purif
h
e
northern
blot
likewis
use
identifi
presenc
cov
sgrna
use
ambion
northernmaxgli
kit
f
detect
design
biotinyl
probe
n
gene
locat
end
genom
allow
detect
viral
rna
speci
present
infect
cell
biotinyl
probe
complementari
code
strand
lower
growth
temperatur
bacteria
help
reduc
plasmid
copi
number
therebi
increas
plasmid
stabil
instanc
insert
fragment
toxic
import
initi
digest
cip
treat
mersa
mersf
fragment
flank
restrict
prevent
inadvert
format
concatem
ensur
seamless
assembl
fragment
use
uv
box
visual
dna
insert
use
creat
final
fulllength
dna
genom
uv
introduc
random
mutat
insert
prevent
viral
replic
reduc
sequenc
fidel
instead
use
bluelight
dark
reader
base
transillumin
box
visual
cut
insert
larg
volum
digest
plasmid
resolv
gel
apparatu
allow
volum
per
well
step
prior
fragment
assembl
execut
condit
merscov
ligat
subsequ
step
must
perform
biosafeti
level
three
contain
lab
point
work
environ
rnase
free
reagent
treat
rnase
zap
similar
treatment
avoid
contamin
rnase
coelectropor
fulllength
viral
rna
cap
ngene
mrna
shown
enhanc
transfect
effici
cov
fulllength
transcript
gener
transcript
reaction
perform
short
time
howev
order
ensur
full
transcript
kb
genom
promot
sequenc
fidel
lower
temperatur
longer
reaction
time
execut
rel
instabl
rna
fulllength
transcript
reaction
perform
day
electropor
typic
h
prior
electropor
cell
detach
trypsin
digest
physic
agit
clean
singlecel
suspens
desir
effici
electropor
subsequ
step
perform
ice
refriger
centrifug
electropor
cocktail
rna
cell
prepar
one
time
subsequ
reaction
prepar
follow
electropor
previous
prepar
cocktail
success
gener
viral
rna
electropor
result
loss
cell
adher
cell
death
within
h
electropor
rang
time
indic
depend
infecti
clone
gener
mutant
virus
may
take
longer
show
cytopath
effect
may
result
lower
overal
viral
titer
particularli
deleteri
mutat
introduc
cytopath
effect
may
seen
secondari
mean
confirm
requir
assess
success
viru
gener
addit
mean
confirm
may
includ
stain
antibodi
visual
immunofluoresc
microscopi
isol
total
rna
cell
lysat
confirm
rtpcr
deleteri
mutat
introduc
clone
sure
sequenc
verifi
passag
subsequ
viru
passag
preferenti
use
viru
assur
sequenc
fidel
expand
viral
stock
passag
cell
cultur
lead
natur
accumul
tissu
cultureadapt
mutat
viral
stock
routin
sequenc
valid
freez
thaw
viru
result
approxim
log
drop
titer
freezethaw
cycl
plate
disturb
ie
move
incub
ensur
clear
identif
plaqu
recommend
run
wildtyp
viru
nonmut
infecti
clone
viru
control
growth
curv
revers
genet
mutant
time
write
chapter
merscov
genom
length
rna
consid
select
agent
therefor
sampl
inactiv
trizol
condit
move
subsequ
work
case
select
agent
like
sarscov
handl
genom
length
rna
fall
feder
select
agent
program
must
handl
accordingli
replic
cov
gener
nest
set
sgrna
intermedi
contain
leader
sequenc
portion
orf
present
cov
genom
utr
fig
result
primer
built
leader
sequenc
ngene
gener
pcr
product
variou
length
repres
cdna
fulllength
sgrna
presenc
sgrna
detect
assum
cov
clone
infecti
replic
compet
